-
-
REFERENCES
[1] Lin, M.J., Svensson-Arvelund, J., Lubitz, G.S., et al. (2022). Cancer vaccines: The next immunotherapy frontier. Nat. Cancer 3: 911-926. DOI: 10.1038/s43018-022-00418-6. [2] Guo, J., De May, H., Franco, S., et al. (2022). Cancer vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns. Nat. Biomed. Eng. 6: 19-31. DOI: 10.1038/s41551-021-00795-w. [3] Marin, I., Boix, O., Garcia-Garijo, A., et al. (2023). Cellular senescence is immunogenic and promotes antitumor immunity. Cancer Discov. 13: 410-431. DOI: 10.1158/2159-8290.CD-22-0523. [4] Chen, H.-A., Ho, Y.-J., Mezzadra, R., et al. (2023). Senescence rewires microenvironment sensing to facilitate antitumor immunity. Cancer Discov. 13: 432-453. DOI: 10.1158/2159-8290.CD-22-0528. [5] Chen, K.-S., Reinshagen, C., Van Schaik, T.A., et al. (2023). Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity. Sci. Transl. Med. 15: eabo4778. DOI: 10.1126/scitranslmed.abo4778. -
ABOUT THIS ARTICLE
Cite this article:
Chen Y. and Zhao Y. (2023). Harnessing whole tumor cells for tumor immunotherapy. The Innovation Materials 1(2), 100018. https://doi.org/10.59717/j.xinn-mater.2023.100018
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Chen Y. and Zhao Y. (2023). Harnessing whole tumor cells for tumor immunotherapy. The Innovation Materials 1(2), 100018. https://doi.org/10.59717/j.xinn-mater.2023.100018
Format
Content
DownLoad:
-
Figure 1.
Schematic illustration for the preparation and antitumor mechanism of whole tumor cell vaccines
